Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-19 4:05 pm Sale | 2024-11-15 | 13G | TFF Pharmaceuticals, Inc. TFFP | Carlson Capital L.P. | 124,000 3.450% | -93,960 (-43.11%) | Filing History |
| 2024-11-14 3:37 pm Purchase | 2024-09-30 | 13G | TFF Pharmaceuticals, Inc. TFFP | ARMISTICE CAPITAL LLC | 359,382 9.990% | 359,382 (New Position) | Filing History |
| 2024-05-08 5:13 pm Purchase | 2024-04-29 | 13G | TFF Pharmaceuticals, Inc. TFFP | Mitchell P. Kopin | 155,589 4.990% | 155,589 (New Position) | Filing History |
| 2024-05-08 4:26 pm Purchase | 2023-12-31 | 13G | TFF Pharmaceuticals, Inc. TFFP | Carlson Capital L.P. | 217,960 9.120% | 144,280 (+195.82%) | Filing History |
| 2024-02-14 6:48 pm Sale | 2023-12-31 | 13G | TFF Pharmaceuticals, Inc. TFFP | LYTTON LAURENCE W | 11,900 0.100% | -113,129 (-90.48%) | Filing History |
| 2023-02-14 3:32 pm Sale | 2022-12-31 | 13G | TFF Pharmaceuticals, Inc. TFFP | Lung Therapeutics Inc. | 30,920 2.100% | -58,480 (-65.41%) | Filing History |
| 2023-02-13 4:03 pm Sale | 2022-12-31 | 13G | TFF Pharmaceuticals, Inc. TFFP | LYTTON LAURENCE W | 125,029 8.400% | -477 (-0.38%) | Filing History |
| 2023-02-09 4:30 pm Sale | 2022-12-31 | 13G | TFF Pharmaceuticals, Inc. TFFP | Carlson Capital L.P. | 73,680 5.100% | -14,080 (-16.04%) | Filing History |
| 2022-11-28 4:17 pm Purchase | 2022-11-22 | 13G | TFF Pharmaceuticals, Inc. TFFP | Carlson Capital L.P. | 87,760 6.200% | 87,760 (New Position) | Filing History |
| 2022-11-23 1:01 pm Purchase | 2022-11-18 | 13G | TFF Pharmaceuticals, Inc. TFFP | LYTTON LAURENCE W | 125,506 8.800% | 125,506 (New Position) | Filing History |
| 2022-02-14 4:10 pm Sale | 2021-12-31 | 13G | TFF Pharmaceuticals, Inc. TFFP | Corriente Advisors LLC | 0 0.000% | -54,000 (Position Closed) | Filing History |
| 2022-02-14 3:07 pm Sale | 2021-12-31 | 13G | TFF Pharmaceuticals, Inc. TFFP | Lung Therapeutics Inc. | 89,400 8.810% | -28,600 (-24.24%) | Filing History |
| 2022-02-14 08:24 am Sale | 2021-12-31 | 13G | TFF Pharmaceuticals, Inc. TFFP | Nantahala Capital Management, LLC | 0 0.000% | -70,539 (Position Closed) | Filing History |
| 2021-02-16 06:33 am Purchase | 2020-12-31 | 13G | TFF Pharmaceuticals, Inc. TFFP | Corriente Advisors LLC | 54,000 6.070% | 54,000 (New Position) | Filing History |
| 2021-02-16 06:25 am Purchase | 2020-12-31 | 13G | TFF Pharmaceuticals, Inc. TFFP | Nantahala Capital Management, LLC | 70,539 7.900% | 70,539 (New Position) | Filing History |
| 2021-02-03 3:10 pm Sale | 2020-12-31 | 13G | TFF Pharmaceuticals, Inc. TFFP | Lung Therapeutics Inc. | 118,000 13.300% | -42,000 (-26.25%) | Filing History |